Search

Your search keyword '"Heussel, Claus Peter"' showing total 824 results
Start Over Author "Heussel, Claus Peter"
824 results on '"Heussel, Claus Peter"'

1. Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007

Author

Rademacher, Jessica, Ewig, Santiago, Grabein, Béatrice, Nachtigall, Irit, Abele-Horn, Marianne, Deja, Maria, Gaßner, Martina, Gatermann, Sören, Geffers, Christine, Gerlach, Herwig, Hagel, Stefan, Heußel, Claus Peter, Kluge, Stefan, Kolditz, Martin, Kramme, Evelyn, Kühl, Hilmar, Panning, Marcus, Rath, Peter-Michael, Rohde, Gernot, Schaaf, Bernhard, Salzer, Helmut J. F., Schreiter, Dierk, Schweisfurth, Hans, Unverzagt, Susanne, Weigand, Markus A., Welte, Tobias, and Pletz, Mathias W.

Published
2024
Full Text
View/download PDF

6. Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)

Author

Trudzinski, Franziska C., Jörres, Rudolf A., Alter, Peter, Watz, Henrik, Vogelmeier, Claus F., Kauczor, Hans-Ulrich, Thangamani, Subasini, Debic, Manuel, Welte, Tobias, Behr, Jürgen, Kahnert, Kathrin, Bals, Robert, Herr, Christian, Heußel, Claus Peter, Biederer, Jürgen, von Stackelberg, Oyunbileg, Fähndrich, Sebastian, Wouters, Emiel F. M., Waschki, Benjamin, Rabe, Klaus F., Herth, Felix J. F., and Palm, Viktoria

Published
2024
Full Text
View/download PDF

15. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas

Author

Goldschmid, Hannah, Kluck, Klaus, Ball, Markus, Kirchner, Martina, Allgäuer, Michael, Winter, Hauke, Herth, Felix, Heußel, Claus-Peter, Pullamsetti, Soni Savai, Savai, Rajkumar, Yong, Timothy Tay Kwang, Schirmacher, Peter, Peters, Solange, Thomas, Michael, Christopoulos, Petros, Budczies, Jan, Stenzinger, Albrecht, and Kazdal, Daniel

Published
2023
Full Text
View/download PDF

16. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

Author

Donnelly, J Peter, Chen, Sharon C, Kauffman, Carol A, Steinbach, William J, Baddley, John W, Verweij, Paul E, Clancy, Cornelius J, Wingard, John R, Lockhart, Shawn R, Groll, Andreas H, Sorrell, Tania C, Bassetti, Matteo, Akan, Hamdi, Alexander, Barbara D, Andes, David, Azoulay, Elie, Bialek, Ralf, Bradsher, Robert W, Bretagne, Stephane, Calandra, Thierry, Caliendo, Angela M, Castagnola, Elio, Cruciani, Mario, Cuenca-Estrella, Manuel, Decker, Catherine F, Desai, Sujal R, Fisher, Brian, Harrison, Thomas, Heussel, Claus Peter, Jensen, Henrik E, Kibbler, Christopher C, Kontoyiannis, Dimitrios P, Kullberg, Bart-Jan, Lagrou, Katrien, Lamoth, Frédéric, Lehrnbecher, Thomas, Loeffler, Jurgen, Lortholary, Olivier, Maertens, Johan, Marchetti, Oscar, Marr, Kieren A, Masur, Henry, Meis, Jacques F, Morrisey, C Orla, Nucci, Marcio, Ostrosky-Zeichner, Luis, Pagano, Livio, Patterson, Thomas F, Perfect, John R, Racil, Zdenek, Roilides, Emmanuel, Ruhnke, Marcus, Prokop, Cornelia Schaefer, Shoham, Shmuel, Slavin, Monica A, Stevens, David A, Thompson, George R, Vazquez, Jose A, Viscoli, Claudio, Walsh, Thomas J, Warris, Adilia, Wheat, L Joseph, White, P Lewis, Zaoutis, Theoklis E, and Pappas, Peter G

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Cancer, Prevention, Clinical Research, Good Health and Well Being, Antifungal Agents, Consensus, Humans, Immunocompromised Host, Invasive Fungal Infections, Mycoses, Neoplasms, consensus, definitions, invasive fungal diseases, diagnosis, research, Biological Sciences, Medical and Health Sciences, Microbiology, Clinical sciences
Abstract

BackgroundInvasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential.MethodsTo achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups' findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved.ResultsThere is no change in the classifications of "proven," "probable," and "possible" IFD, although the definition of "probable" has been expanded and the scope of the category "possible" has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses.ConclusionsThese updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.

Published
2020

17. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Author

Cornely, Oliver A, Alastruey-Izquierdo, Ana, Arenz, Dorothee, Chen, Sharon CA, Dannaoui, Eric, Hochhegger, Bruno, Hoenigl, Martin, Jensen, Henrik E, Lagrou, Katrien, Lewis, Russell E, Mellinghoff, Sibylle C, Mer, Mervyn, Pana, Zoi D, Seidel, Danila, Sheppard, Donald C, Wahba, Roger, Akova, Murat, Alanio, Alexandre, Al-Hatmi, Abdullah MS, Arikan-Akdagli, Sevtap, Badali, Hamid, Ben-Ami, Ronen, Bonifaz, Alexandro, Bretagne, Stéphane, Castagnola, Elio, Chayakulkeeree, Methee, Colombo, Arnaldo L, Corzo-León, Dora E, Drgona, Lubos, Groll, Andreas H, Guinea, Jesus, Heussel, Claus-Peter, Ibrahim, Ashraf S, Kanj, Souha S, Klimko, Nikolay, Lackner, Michaela, Lamoth, Frederic, Lanternier, Fanny, Lass-Floerl, Cornelia, Lee, Dong-Gun, Lehrnbecher, Thomas, Lmimouni, Badre E, Mares, Mihai, Maschmeyer, Georg, Meis, Jacques F, Meletiadis, Joseph, Morrissey, C Orla, Nucci, Marcio, Oladele, Rita, Pagano, Livio, Pasqualotto, Alessandro, Patel, Atul, Racil, Zdenek, Richardson, Malcolm, Roilides, Emmanuel, Ruhnke, Markus, Seyedmousavi, Seyedmojtaba, Sidharthan, Neeraj, Singh, Nina, Sinko, János, Skiada, Anna, Slavin, Monica, Soman, Rajeev, Spellberg, Brad, Steinbach, William, Tan, Ban Hock, Ullmann, Andrew J, Vehreschild, Jörg J, Vehreschild, Maria JGT, Walsh, Thomas J, White, P Lewis, Wiederhold, Nathan P, Zaoutis, Theoklis, Chakrabarti, Arunaloke, and Group, Mucormycosis ECMM MSG Global Guideline Writing

Subjects
Clinical Research, Good Health and Well Being, Disease Management, Humans, Mucormycosis, Mucormycosis ECMM MSG Global Guideline Writing Group, Clinical Sciences, Medical Microbiology, Public Health and Health Services, Microbiology
Abstract

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidisciplinary management has potential to improve prognosis, but approaches differ between health-care settings. From January, 2018, authors from 33 countries in all United Nations regions analysed the published evidence on mucormycosis management and provided consensus recommendations addressing differences between the regions of the world as part of the "One World One Guideline" initiative of the European Confederation of Medical Mycology (ECMM). Diagnostic management does not differ greatly between world regions. Upon suspicion of mucormycosis appropriate imaging is strongly recommended to document extent of disease and is followed by strongly recommended surgical intervention. First-line treatment with high-dose liposomal amphotericin B is strongly recommended, while intravenous isavuconazole and intravenous or delayed release tablet posaconazole are recommended with moderate strength. Both triazoles are strongly recommended salvage treatments. Amphotericin B deoxycholate is recommended against, because of substantial toxicity, but may be the only option in resource limited settings. Management of mucormycosis depends on recognising disease patterns and on early diagnosis. Limited availability of contemporary treatments burdens patients in low and middle income settings. Areas of uncertainty were identified and future research directions specified.

Published
2019

23. Asynchronous calibration of quantitative computed tomography bone mineral density assessment for opportunistic osteoporosis screening: phantom-based validation and parameter influence evaluation

Author

Skornitzke, Stephan, Vats, Neha, Kopytova, Taisiya, Tong, Elizabeth Wai Yee, Hofbauer, Tobias, Weber, Tim Frederik, Rehnitz, Christoph, von Stackelberg, Oyunbileg, Maier-Hein, Klaus, Stiller, Wolfram, Biederer, Jürgen, Kauczor, Hans-Ulrich, Heußel, Claus-Peter, Wielpütz, Mark, and Palm, Viktoria

Published
2022
Full Text
View/download PDF

24. Cine-MRI and T1TSE Sequence for Mediastinal Mass.

Author

Grott, Matthias, Khan, Nabil, Eichhorn, Martin E., Heussel, Claus Peter, Winter, Hauke, and Eichinger, Monika

Subjects
DIAGNOSTIC imaging, CANCER invasiveness, PERICARDIUM, HEART atrium, COMPUTED tomography, PULMONARY artery, MAGNETIC resonance imaging, RETROSPECTIVE studies, MEDIASTINAL tumors, AORTA, MEDICAL records, ACQUISITION of data, MYOCARDIUM, TUMOR classification
Abstract

Simple Summary: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating mediastinal tumors. In equivocal cases, cine magnetic resonance imaging (cine-MRI) and magnetic resonance imaging (MRI)/T1-weighted spin echo sequences (T1TSE) may be additionally performed. We retrospectively analyzed patients undergoing surgical resection of mediastinal tumors (benign and malignant) with prior CT, cine-MRI, and T1TSE for (re-)evaluation and comparison to the intraoperative findings and postoperative histology reports, which were defined as a gold standard. Unclear CT cases were further investigated. A total of 47 patients were included in the study. Cine-MRI is of crucial benefit in unclear CT findings compared with T1TSE, especially when infiltration into the large central vessels and atria is suspected. Background/Objectives: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating the extent of mediastinal tumors. If tumor infiltration into the large central thoracic vessels, the pericardium, or the myocardium is suspected, cine magnetic resonance imaging (cine-MRI) can provide additional valuable information. Methods: We conducted a retrospective study of patients with mediastinal tumors who were staged with CT, cine-MRI, and a T1-weighted turbo spin echo (T1TSE) prior to surgical resection. Imaging was re-evaluated regarding tumor infiltration into the pericardium, myocardium, superior vena cava, aorta, pulmonary arteries, and atria and compared with intraoperative findings and postoperative histopathological reports (gold standard). Unclear CT findings were further investigated. Results: Forty-seven patients (29 female and 18 male patients; median age: 58 years) met the inclusion criteria. Cine-MRI was able to predict infiltration of the aorta in 86%, pulmonary arteries in 85%, and atria in 80% of unclear CT cases. Aortic tumor infiltration in unclear CT cases was significantly more often correctly diagnosed with cine-MRI than with T1TSE sequence. Conclusions: Additional cine-MRI is of crucial benefit in unclear CT cases. We recommend performing cine-MRI if infiltration into the large central vessels and atria is suspected. T1TSE sequence is of very limited additional value. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

Author

Budczies, Jan, Kirchner, Martina, Kluck, Klaus, Kazdal, Daniel, Glade, Julia, Allgäuer, Michael, Kriegsmann, Mark, Heußel, Claus-Peter, Herth, Felix J., Winter, Hauke, Meister, Michael, Muley, Thomas, Goldmann, Torsten, Fröhling, Stefan, Wermke, Martin, Waller, Cornelius F., Tufman, Amanda, Reck, Martin, Peters, Solange, Schirmacher, Peter, Thomas, Michael, Christopoulos, Petros, and Stenzinger, Albrecht

Published
2022
Full Text
View/download PDF

26. Diagnostic Potential of Supplemental Static and Dynamic68Ga-FAPI-46 PET for Primary18F-FDG–Negative Pulmonary Lesions

Author

Röhrich, Manuel, primary, Daum, Johanna, additional, Gutjahr, Ewgenija, additional, Spektor, Anna-Maria, additional, Glatting, Frederik M., additional, Sahin, Yasemin Aylin, additional, Buchholz, Hans Georg, additional, Hoppner, Jorge, additional, Schroeter, Cathrin, additional, Mavriopoulou, Eleni, additional, Schlamp, Kai, additional, Grott, Matthias, additional, Eichhorn, Florian, additional, Heußel, Claus Peter, additional, Kauczor, Hans Ulrich, additional, Kreuter, Michael, additional, Giesel, Frederik, additional, Schreckenberger, Mathias, additional, Winter, Hauke, additional, and Haberkorn, Uwe, additional

Published
2024
Full Text
View/download PDF

27. Capturing COPD heterogeneity: anomaly detection and parametric response mapping comparison for phenotyping on chest computed tomography

Author

Almeida, Silvia D., primary, Norajitra, Tobias, additional, Lüth, Carsten T., additional, Wald, Tassilo, additional, Weru, Vivienn, additional, Nolden, Marco, additional, Jäger, Paul F., additional, von Stackelberg, Oyunbileg, additional, Heußel, Claus Peter, additional, Weinheimer, Oliver, additional, Biederer, Jürgen, additional, Kauczor, Hans-Ulrich, additional, and Maier-Hein, Klaus, additional

Published
2024
Full Text
View/download PDF

28. The Radiology Consult

Author

Silva, Carlos Francisco, Heussel, Claus Peter, Mortani Barbosa, Eduardo, Jr., Kauczor, Hans-Ulrich, Series Editor, Parizel, Paul M., Series Editor, Peh, Wilfred C. G., Series Editor, Brady, Luther W, Series Editor, Lu, Jiade J., Series Editor, Silva, Carlos Francisco, editor, and von Stackelberg, Oyunbileg, editor

Published
2020
Full Text
View/download PDF

29. Multicenter Standardization of Phase-Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension

Author

Moher Alsady, Tawfik; https://orcid.org/0000-0002-0779-0688, Voskrebenzev, Andreas, Behrendt, Lea, Olsson, Karen, Heußel, Claus Peter, Gruenig, Ekkehard, Gall, Henning, Ghofrani, Ardeschir, Roller, Fritz, Harth, Sebastian; https://orcid.org/0000-0001-5272-2716, Marshall, Helen; https://orcid.org/0000-0002-7425-1449, Hughes, Paul J C; https://orcid.org/0000-0002-7979-5840, Wild, Jim; https://orcid.org/0000-0002-7246-8660, Swift, Andrew J, Kiely, David G, Behr, Jürgen, Dinkel, Julien, Beitzke, Dietrich; https://orcid.org/0000-0003-3179-3827, Lang, Irene M, Schmidt, Kai Helge, Kreitner, Karl Friedrich, Frauenfelder, Thomas, Ulrich, Silvia, Hamer, Okka W, Vogel-Claussen, Jens, Moher Alsady, Tawfik; https://orcid.org/0000-0002-0779-0688, Voskrebenzev, Andreas, Behrendt, Lea, Olsson, Karen, Heußel, Claus Peter, Gruenig, Ekkehard, Gall, Henning, Ghofrani, Ardeschir, Roller, Fritz, Harth, Sebastian; https://orcid.org/0000-0001-5272-2716, Marshall, Helen; https://orcid.org/0000-0002-7425-1449, Hughes, Paul J C; https://orcid.org/0000-0002-7979-5840, Wild, Jim; https://orcid.org/0000-0002-7246-8660, Swift, Andrew J, Kiely, David G, Behr, Jürgen, Dinkel, Julien, Beitzke, Dietrich; https://orcid.org/0000-0003-3179-3827, Lang, Irene M, Schmidt, Kai Helge, Kreitner, Karl Friedrich, Frauenfelder, Thomas, Ulrich, Silvia, Hamer, Okka W, and Vogel-Claussen, Jens

Abstract

BACKGROUND: Detection of pulmonary perfusion defects is the recommended approach for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This is currently achieved in a clinical setting using scintigraphy. Phase-resolved functional lung (PREFUL) magnetic resonance imaging (MRI) is an alternative technique for evaluating regional ventilation and perfusion without the use of ionizing radiation or contrast media. PURPOSE: To assess the feasibility and image quality of PREFUL-MRI in a multicenter setting in suspected CTEPH. STUDY TYPE: This is a prospective cohort sub-study. POPULATION: Forty-five patients (64 ± 16 years old) with suspected CTEPH from nine study centers. FIELD STRENGTH/SEQUENCE: 1.5 T and 3 T/2D spoiled gradient echo/bSSFP/T2 HASTE/3D MR angiography (TWIST). ASSESSMENT: Lung signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were compared between study centers with different MRI machines. The contrast between normally and poorly perfused lung areas was examined on PREFUL images. The perfusion defect percentage calculated using PREFUL-MRI (QDP$_{PREFUL}$ ) was compared to QDP from the established dynamic contrast-enhanced MRI technique (QDP$_{DCE}$ ). Furthermore, QDP$_{PREFUL}$ was compared between a patient subgroup with confirmed CTEPH or chronic thromboembolic disease (CTED) to other clinical subgroups. STATISTICAL TESTS: t-Test, one-way analysis of variance (ANOVA), Pearson's correlation. Significance level was 5%. RESULTS: Significant differences in lung SNR and CNR were present between study centers. However, PREFUL perfusion images showed a significant contrast between normally and poorly perfused lung areas (mean delta of normalized perfusion -4.2% SD 3.3) with no differences between study sites (ANOVA: P = 0.065). QDP$_{PREFUL}$ was significantly correlated with QDP$_{DCE}$ (r = 0.66), and was significantly higher in 18 patients with confirmed CTEPH or CTED (57.9 ± 12.2%) compared to subgroups with other causes of PH or

Published
2024

30. Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions.

Author

Röhrich, Manuel, Daum, Johanna, Gutjahr, Ewgenija, Spektor, Anna-Maria, Glatting, Frederik M., Sahin, Yasemin Aylin, Buchholz, Hans Georg, Hoppner, Jorge, Schroeter, Cathrin, Mavriopoulou, Eleni, Schlamp, Kai, Grott, Matthias, Eichhorn, Florian, Heußel, Claus Peter, Kauczor, Hans Ulrich, Kreuter, Michael, Giesel, Frederik, Schreckenberger, Mathias, Winter, Hauke, and Haberkorn, Uwe

Published
2024
Full Text
View/download PDF

31. Novel chimeric antigen receptors for the effective and safe treatment of NY‐BR‐1 positive breast cancer.

Author

Jäger, Dirk, Berger, Aileen, Tuch, Alexandra, Luckner‐Minden, Claudia, Eurich, Rosa, Hlevnjak, Mario, Schneeweiss, Andreas, Lichter, Peter, Aulmann, Sebastian, Heussel, Claus‐Peter, Fremd, Carlo, Harbottle, Richard, Zörnig, Inka, and Schmidt, Patrick

Subjects
TWO-way analysis of variance, METASTATIC breast cancer, GENE expression, ONE-way analysis of variance, GENETIC engineering, LOBULAR carcinoma
Abstract

This article discusses the development of novel chimeric antigen receptors (CARs) for the treatment of NY-BR-1 positive breast cancer. The authors conducted expression analyses to determine the frequency of NY-BR-1 expression in breast cancer and found that it is prevalent in ER+ and HER2+ disease. They also identified the binding epitopes of two novel antibodies that specifically target NY-BR-1 without cross-reactivity. In in vivo experiments, the CAR-T cells engineered with these antibodies showed reduced tumor growth and prolonged survival in mice. The authors conclude that these CAR-T cells could be suitable candidates for a Phase I clinical trial. [Extracted from the article]

Published
2024
Full Text
View/download PDF

32. Multicenter Standardization of Phase‐Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension.

Author

Moher Alsady, Tawfik, Voskrebenzev, Andreas, Behrendt, Lea, Olsson, Karen, Heußel, Claus Peter, Gruenig, Ekkehard, Gall, Henning, Ghofrani, Ardeschir, Roller, Fritz, Harth, Sebastian, Marshall, Helen, Hughes, Paul J.C., Wild, Jim, Swift, Andrew J., Kiely, David G., Behr, Jürgen, Dinkel, Julien, Beitzke, Dietrich, Lang, Irene M., and Schmidt, Kai Helge

Subjects
FUNCTIONAL magnetic resonance imaging, PULMONARY hypertension, MAGNETIC resonance imaging, PEARSON correlation (Statistics), CONTRAST-enhanced magnetic resonance imaging
Abstract

Background: Detection of pulmonary perfusion defects is the recommended approach for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). This is currently achieved in a clinical setting using scintigraphy. Phase‐resolved functional lung (PREFUL) magnetic resonance imaging (MRI) is an alternative technique for evaluating regional ventilation and perfusion without the use of ionizing radiation or contrast media. Purpose: To assess the feasibility and image quality of PREFUL‐MRI in a multicenter setting in suspected CTEPH. Study Type: This is a prospective cohort sub‐study. Population: Forty‐five patients (64 ± 16 years old) with suspected CTEPH from nine study centers. Field Strength/Sequence: 1.5 T and 3 T/2D spoiled gradient echo/bSSFP/T2 HASTE/3D MR angiography (TWIST). Assessment: Lung signal‐to‐noise ratio (SNR) and contrast‐to‐noise ratio (CNR) were compared between study centers with different MRI machines. The contrast between normally and poorly perfused lung areas was examined on PREFUL images. The perfusion defect percentage calculated using PREFUL‐MRI (QDPPREFUL) was compared to QDP from the established dynamic contrast‐enhanced MRI technique (QDPDCE). Furthermore, QDPPREFUL was compared between a patient subgroup with confirmed CTEPH or chronic thromboembolic disease (CTED) to other clinical subgroups. Statistical Tests: t‐Test, one‐way analysis of variance (ANOVA), Pearson's correlation. Significance level was 5%. Results: Significant differences in lung SNR and CNR were present between study centers. However, PREFUL perfusion images showed a significant contrast between normally and poorly perfused lung areas (mean delta of normalized perfusion −4.2% SD 3.3) with no differences between study sites (ANOVA: P = 0.065). QDPPREFUL was significantly correlated with QDPDCE (r = 0.66), and was significantly higher in 18 patients with confirmed CTEPH or CTED (57.9 ± 12.2%) compared to subgroups with other causes of PH or with excluded PH (in total 27 patients with mean ± SD QDPPREFUL = 33.9 ± 17.2%). Data Conclusion: PREFUL‐MRI could be considered as a non‐invasive method for imaging regional lung perfusion in multicenter studies. Level of Evidence: 3 Technical Efficacy: Stage 1 [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. CT of the Airways

Author

Trojan, Michael, Kauczor, Hans-Ulrich, Heußel, Claus Peter, Wielpütz, Mark Oliver, Kauczor, Hans-Ulrich, Series Editor, Parizel, Paul M., Series Editor, Peh, Wilfred C. G., Series Editor, Brady, Luther W., Honorary Editor, Lu, Jiade J., Series Editor, Nikolaou, Konstantin, editor, Bamberg, Fabian, editor, Laghi, Andrea, editor, and Rubin, Geoffrey D., editor

Published
2019
Full Text
View/download PDF

34. Efficacy and Safety of Simultaneous Combined Endobronchial and Intrabronchial Valve Therapy in Patients with Advanced Pulmonary Emphysema

Author

Dittrich, A. Susanne, primary, Kontogianni, Konstantina, additional, Unterschemmann, Ann-Sophie, additional, De Rossi, Susanne, additional, Trudzinski, Franziska, additional, Brock, Judith Maria, additional, Gompelmann, Daniela, additional, Heußel, Claus-Peter, additional, Herth, Felix J., additional, and Eberhardt, Ralf, additional

Published
2024
Full Text
View/download PDF

35. Prediction of disease severity in COPD: a deep learning approach for anomaly-based quantitative assessment of chest CT

Author

Almeida, Silvia D., primary, Norajitra, Tobias, additional, Lüth, Carsten T., additional, Wald, Tassilo, additional, Weru, Vivienn, additional, Nolden, Marco, additional, Jäger, Paul F., additional, von Stackelberg, Oyunbileg, additional, Heußel, Claus Peter, additional, Weinheimer, Oliver, additional, Biederer, Jürgen, additional, Kauczor, Hans-Ulrich, additional, and Maier-Hein, Klaus, additional

Published
2023
Full Text
View/download PDF

36. Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis

Author

Merkt, Wolfgang, primary, Freitag, Merle, additional, Claus, Maren, additional, Kolb, Philipp, additional, Falcone, Valeria, additional, Röhrich, Manuel, additional, Rodon, Lea, additional, Deicher, Franca, additional, Andreeva, Ivana, additional, Tretter, Theresa, additional, Tykocinski, Lars-Oliver, additional, Blank, Norbert, additional, Watzl, Carsten, additional, Schmitt, Anita, additional, Sauer, Tim, additional, Müller-Tidow, Carsten, additional, Polke, Markus, additional, Heußel, Claus Peter, additional, Dreger, Peter, additional, Lorenz, Hanns-Martin, additional, and Schmitt, Michael, additional

Published
2023
Full Text
View/download PDF

37. A reporting and analysis framework for structured evaluation of COVID-19 clinical and imaging data

Author

Salg, Gabriel Alexander, Ganten, Maria-Katharina, Bucher, Andreas Michael, Kenngott, Hannes Goetz, Fink, Matthias Alexander, Seibold, Constantin, Fischbach, Ricarda Elisabeth, Schlamp, Kai, Velandia, Carlos Alberto, Fervers, Philipp, Doellinger, Felix, Luger, Anna, Afat, Saif, Merle, Uta, Diener, Markus K., Pereira, Philippe L., Penzkofer, Tobias, Persigehl, Thorsten, Othman, Ahmed, Heußel, Claus Peter, Baumhauer, Matthias, Widmann, Gerlig, Stathopoulos, Konstantinos, Hamm, Bernd, Vogl, Thomas J., Nikolaou, Konstantin, Kauczor, Hans-Ulrich, and Kleesiek, Jens

Published
2021
Full Text
View/download PDF

39. Diseases of the Pleura and the Chest Wall

Author

Heussel, Claus Peter, Wielpütz, Mark Oliver, Kauczor, Hans-Ulrich, Kauczor, Hans-Ulrich, Series Editor, Parizel, Paul M., Series Editor, Peh, Wilfred C. G., Series Editor, and Wielpütz, Mark Oliver, editor

Published
2018
Full Text
View/download PDF

42. CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan

Author

Muley, Thomas, primary, Schneider, Mark A., additional, Meister, Michael, additional, Thomas, Michael, additional, Heußel, Claus Peter, additional, Kriegsmann, Mark, additional, Holdenrieder, Stefan, additional, Wehnl, Birgit, additional, Rolny, Vinzent, additional, Mang, Anika, additional, Gerber, Rebecca, additional, and Herth, Felix, additional

Published
2023
Full Text
View/download PDF

48. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices

Author

Bernhardt, Denise, König, Laila, Aufderstrasse, Sophie, Krisam, Johannes, Hoerner-Rieber, Juliane, Adeberg, Sebastian, Bozorgmehr, Farastuk, El Shafie, Rami, Lang, Kristin, Kappes, Jutta, Thomas, Michael, Herth, Felix, Heußel, Claus Peter, Warth, Arne, Marcrom, Samuel, Debus, Jürgen, Steins, Martin, and Rieken, Stefan

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results